Ann: Living Insights Newsletter September 2019, page-7

It has been a long haul. Now we are told:

" The resources required inmanufacturing, regulatory approval andplacement of an international study areconsiderable and require in-depth duediligence. It would be a five-yearcommitment at least. A further largestudy would require significant additionalcapital, which the company does notcurrently have. "

A pity about that, but the time has come for me to direct my hopes for an effective therapy elsewhere. For anyone else in this situation I would suggest you look at the work being undertaken at the Univ of Queensland into the use of a drug (CuATSM) which they plan to take into a Phase 2 study later this year.

Given the 5+ years before NTCELL possibly delivers, it looks unlikely now that I'll be able to tell people that there is a good reason why I am pigheaded.